Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H18FN5O2 |
| Molecular Weight | 403.409 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC=CC=C1C2=CC3=C(NCC4=C(F)C=CC5=C4[C@H](CO5)CO3)N6C=NN=C26
InChI
InChIKey=JQBUTSBIFNKJMW-CYBMUJFWSA-N
InChI=1S/C22H18FN5O2/c1-12-14(3-2-6-24-12)15-7-19-22(28-11-26-27-21(15)28)25-8-16-17(23)4-5-18-20(16)13(9-29-18)10-30-19/h2-7,11,13,25H,8-10H2,1H3/t13-/m1/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
862121
Created by
admin on Wed Apr 02 14:31:32 GMT 2025 , Edited by admin on Wed Apr 02 14:31:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2490674-02-5
Created by
admin on Wed Apr 02 14:31:32 GMT 2025 , Edited by admin on Wed Apr 02 14:31:32 GMT 2025
|
PRIMARY | |||
|
BC2SSV7WMT
Created by
admin on Wed Apr 02 14:31:32 GMT 2025 , Edited by admin on Wed Apr 02 14:31:32 GMT 2025
|
PRIMARY | |||
|
12321
Created by
admin on Wed Apr 02 14:31:32 GMT 2025 , Edited by admin on Wed Apr 02 14:31:32 GMT 2025
|
PRIMARY | |||
|
LM-160
Created by
admin on Wed Apr 02 14:31:32 GMT 2025 , Edited by admin on Wed Apr 02 14:31:32 GMT 2025
|
PRIMARY | |||
|
C190423
Created by
admin on Wed Apr 02 14:31:32 GMT 2025 , Edited by admin on Wed Apr 02 14:31:32 GMT 2025
|
PRIMARY | |||
|
300000051036
Created by
admin on Wed Apr 02 14:31:32 GMT 2025 , Edited by admin on Wed Apr 02 14:31:32 GMT 2025
|
PRIMARY | |||
|
155128494
Created by
admin on Wed Apr 02 14:31:32 GMT 2025 , Edited by admin on Wed Apr 02 14:31:32 GMT 2025
|
PRIMARY |
ACTIVE MOIETY